Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer

Blood

Volumn 118, Issue 13, 2011, Pages 3725-3733

  Aalto, Kristiina ^a   Autio, Anu ^b   Kiss, Elina A ^a   Elima, Kati ^a,b   Nymalm, Yvonne ^c   Veres, Tibor Z ^a   Marttila Ichihara, Fumiko ^a   Elovaara, Heli ^a   Saanijoki, Tiina ^b   Crocker, Paul R ^d   Maksimow, Mikael ^a   Bligt, Eva ^c   Salminen, Tiina A ^c   Salmi, Marko ^a,b,e   Roivainen, Anne ^b   Jalkanen, Sirpa ^a,e  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c ÅBO AKADEMI UNIVERSITY   (Finland)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GALLIUM 68; LIGAND; MUTANT PROTEIN; SIGLEC 9; UNCLASSIFIED DRUG; VASCULAR ADHESION PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; CONTROLLED STUDY; ENZYME ACTIVITY; EX VIVO STUDY; GRANULOCYTE; IN VITRO STUDY; INFLAMMATION; LEUKOCYTE; MOLECULAR MODEL; MOUSE; NEOPLASM; NONHUMAN; PHAGE DISPLAY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BINDING; RAT;

EID: 80053364442     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-09-311076     Document Type: Article

References (37)

1. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell. 1991;67(6):1033-1036. (Pubitemid 121001517)
2. Zarbock A, Ley K. Mechanisms and consequences of neutrophil interaction with the endothelium. Am J Pathol. 2008;172(1):1-7. (Pubitemid 351186361)
3. Salmi M, Jalkanen S. Cell-surface enzymes in control of leukocyte trafficking. Nat Rev Immunol. 2005;5(10):760-771. (Pubitemid 41400850)
4. Lalor PF, Sun PJ, Weston CJ, Martin-Santos A, Wakelam MJ, Adams DH. Activation of vascular adhesion protein-1 on liver endothelium results in an NF-kappaB-dependent increase in lymphocyte adhesion. Hepatology. 2007;45(2):465-474. (Pubitemid 46374603)
5. Jalkanen S, Karikoski M, Mercier N, et al. The oxidase activity of vascular adhesion protein-1 (VAP-1) induces endothelial E- and P-selectins and leukocyte binding. Blood. 2007;110(6):1864-1870. (Pubitemid 47443898)
6. Kivi E, Elima K, Aalto K, et al. Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrate. Blood. 2009;114(26):5385-5392.
7. Munday J, Kerr S, Ni J, et al. Identification, characterization and leucocyte expression of Siglec- 10, a novel human sialic acid-binding receptor. Biochem J. 2001;355(2):489-497. (Pubitemid 32397810)
8. Koskinen K, Vainio PJ, Smith DJ, et al. Granulocyte transmigration through the endothelium is regulated by the oxidase activity of vascular adhesion protein-1 (VAP-1). Blood. 2004;103(9):3388-3395. (Pubitemid 38525669)
9. Merinen M, Irjala H, Salmi M, Jaakkola I, Hanninen A, Jalkanen S. Vascular adhesion protein-1 is involved in both acute and chronic inflammation in the mouse. Am J Pathol. 2005;166(3):793-800. (Pubitemid 40315636)
10. O'Rourke AM, Wang EY, Miller A, et al. Antiinflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity. J Pharmacol Exp Ther. 2008;324(2):867-875. (Pubitemid 351185861)
11. Bonder CS, Norman MU, Swain MG, et al. Rules of recruitment for Th1 and Th2 lymphocytes in inflamed liver: a role for alpha-4 integrin and vascular adhesion protein-1. Immunity. 2005;23(2):153-163. (Pubitemid 41169285)
12. Tohka S, Laukkanen M, Jalkanen S, Salmi M. Vascular adhesion protein 1 (VAP-1) functions as a molecular brake during granulocyte rolling and mediates recruitment in vivo. FASEB J. 2001;15(2):373-382. (Pubitemid 32141429)
13. Kurkijarvi R, Adams DH, Leino R, Mottonen T, Jalkanen S, Salmi M. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases. J Immunol. 1998;161(3):1549-1557. (Pubitemid 28380589)
14. Salmi M, Koskinen K, Henttinen T, Elima K, Jalkanen S. CLEVER-1 mediates lymphocyte transmigration through vascular and lymphatic endothelium. Blood. 2004;104(13):3849-3857. (Pubitemid 39620128)
15. Salmi M, Jalkanen S. A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science. 1992;257(5075):1407-1409.
16. Jalkanen ST, Bargatze RF, Herron LR, Butcher EC. Alymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man. Eur J Immunol. 1986;16(10):1195-1202. (Pubitemid 17171524)
17. Koivunen E, Arap W, Rajotte D, Lahdenranta J, Pasqualini R. Identification of receptor ligands with phage display peptide libraries. J Nucl Med. 1999;40(5):883-888. (Pubitemid 29210767)
18. Salmi M, Tohka S, Jalkanen S. Human vascular adhesion protein-1 (VAP-1) plays a critical role in lymphocyte-endothelial cell adhesion cascade under shear. Circ Res. 2000;86(12):1245-1251. (Pubitemid 30436665)
19. Bono P, Jalkanen S, Salmi M. Mouse vascular adhesion protein 1 is a sialoglycoprotein with enzymatic activity and is induced in diabetic insulitis. Am J Pathol. 1999;155(5):1613-1624.
20. Salmi M, Jalkanen S. Human leukocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules. J Immunol. 2001;166(7):4650-4657. (Pubitemid 32233752)
21. Stolen CM, Marttila-Ichihara F, Koskinen K, et al. Absence of the endothelial oxidase AOC3 leads to abnormal leukocyte traffic in vivo. Immunity. 2005;22(1):105-115. (Pubitemid 40143455)
22. Dunne JL, Collins RG, Beaudet AL, Ballantyne CM, Ley K. Mac-1, but not LFA-1, uses intercellular adhesion molecule-1 to mediate slow leukocyte rolling in TNF-alpha-induced inflammation. J Immunol. 2003;171(11):6105-6111. (Pubitemid 37467232)
23. Zhuravleva MA, Trandem K, Sun PD. Structural implications of Siglec-5-mediated sialoglycan recognition. J Mol Biol. 2008;375(2):437-447. (Pubitemid 350192476)
24. Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol. 1993;234(3):779-815. (Pubitemid 24007801)
25. Johnson MS, Overington JP. A structural basis for sequence comparisons: an evaluation of scoring methodologies. J Mol Biol. 1993;233(4):716-738. (Pubitemid 23314782)
26. Lehtonen JV, Still DJ, Rantanen VV, et al. BODIL: a molecular modeling environment for structure-function analysis and drug design. J Comput Aided Mol Des. 2004;18(6):401-419. (Pubitemid 40069138)
27. Airenne TT, Nymalm Y, Kidron H, et al. Crystal structure of the human vascular adhesion protein-1: unique structural features with functional implications. Protein Sci. 2005;14(8):1964-1974. (Pubitemid 41132362)
28. Jones G, Willett P, Glen RC. Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. J Mol Biol. 1995;245(1):43-53.
29. Jones G, Willett P, Glen RC, Leach AR, Taylor R. Development and validation of a genetic algorithm for flexible docking. J Mol Biol. 1997;267(3):727-748. (Pubitemid 27170693)
30. Ujula T, Salomaki S, Virsu P, et al. Synthesis, 68Ga labeling and preliminary evaluation of DOTA peptide binding vascular adhesion protein-1: a potential PET imaging agent for diagnosing osteomyelitis. Nucl Med Biol. 2009;36(6):631-641.
31. Goodarzi K, Goodarzi M, Tager AM, Luster AD, Von Andrian UH. Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat Immunol. 2003;4(10):965-973. (Pubitemid 37265917)
32. Marttila-Ichihara F, Auvinen K, Elima K, Jalkanen S, Salmi M. Vascular adhesion protein-1 enhances tumor growth by supporting recruitment of Gr-1+CD11b+myeloid cells into tumors. Cancer Res. 2009;69(19):7875-7883.
33. Keuschnigg J, Henttinen T, Auvinen K, Karikoski M, Salmi M, Jalkanen S. The prototype endothelial marker PAL-E is a leukocyte trafficking molecule. Blood. 2009;114(2):478-484.
34. Jaakkola K, Nikula T, Holopainen R, et al. In vivo detection of vascular adhesion protein-1 in experimental inflammation. Am J Pathol. 2000;157(2):463-471. (Pubitemid 30626909)
35. Fonsatti E, Jekunen A, Kairemo K, et al. Endoglin is a suitable target for efficient imaging of solid tumors: in vivo evidence in a canine mammary carcinoma model. Clin Cancer Res. 2000;6(5):2037-2043. (Pubitemid 30305103)
36. Garrood T, Blades M, Haskard DO, Mather S, Pitzalis C. A novel model for the pre-clinical imaging of inflamed human synovial vasculature. Rheumatology (Oxford). 2009;48(8):926-931.
37. Malviya G, Conti F, Chianelli M, Scopinaro F, Dierckx RA, Signore A. Molecular imaging of rheumatoid arthritis by radiolabelled monoclonal antibodies: new imaging strategies to guide molecular therapies. Eur J Nucl Med Mol Imaging. 2010;37(2):386-398.